These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1788163)

  • 1. Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.
    Ashton P; Podder SK; Lee VH
    Pharm Res; 1991 Sep; 8(9):1166-74. PubMed ID: 1788163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration.
    Wang W; Sasaki H; Chien DS; Lee VH
    Curr Eye Res; 1991 Jun; 10(6):571-9. PubMed ID: 1680041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.
    Sasaki H; Igarashi Y; Nagano T; Nishida K; Nakamura J
    Pharm Res; 1995 Aug; 12(8):1146-50. PubMed ID: 7494826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit.
    Shih RL; Lee VH
    J Ocul Pharmacol; 1990; 6(4):329-36. PubMed ID: 1982948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
    Chung YB; Han K; Nishiura A; Lee VH
    Pharm Res; 1998 Dec; 15(12):1882-7. PubMed ID: 9892473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit.
    Ashton P; Wang W; Lee VH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):719-24. PubMed ID: 1941620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
    Lee YH; Kompella UB; Lee VH
    Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.
    Fayyaz A; Vellonen KS; Ranta VP; Toropainen E; Reinisalo M; Valtari A; Puranen J; Ricci GD; Heikkinen EM; Gardner I; Ruponen M; Urtti A; Jamei M; Del Amo EM
    Eur J Pharm Biopharm; 2021 Sep; 166():155-162. PubMed ID: 34139290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of ocular permeability of peptide drugs by absorption promoters.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 2000 Dec; 23(12):1524-7. PubMed ID: 11145191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.
    Chien DS; Sasaki H; Bundgaard H; Buur A; Lee VH
    Pharm Res; 1991 Jun; 8(6):728-33. PubMed ID: 2062802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.
    Sasaki H; Yamamura K; Tei C; Nishida K; Nakamura J
    J Drug Target; 1995; 3(2):129-35. PubMed ID: 7496726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
    Ahmed I; Patton TF
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition.
    Podder SK; Moy KC; Lee VH
    Exp Eye Res; 1992 May; 54(5):747-57. PubMed ID: 1623960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.
    Lee VH; Chien DS; Sasaki H
    J Pharmacol Exp Ther; 1988 Sep; 246(3):871-8. PubMed ID: 3047365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
    Lee VH; Yamahara H; Gurny R; Sintzel MB; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder SK
    J Ocul Pharmacol Ther; 1996; 12(2):103-13. PubMed ID: 8773926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of timolol, betaxolol and levobunolol on the surface of rabbit cornea.
    Follmann P; Varga M; Daróczy J
    Int Ophthalmol; 1989 Jan; 13(1-2):81-4. PubMed ID: 2663750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival penetration of insulin and peptide drugs in the albino rabbit.
    Hayakawa E; Chien DS; Inagaki K; Yamamoto A; Wang W; Lee VH
    Pharm Res; 1992 Jun; 9(6):769-75. PubMed ID: 1384027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug delivery using 20-kHz ultrasound.
    Zderic V; Vaezy S; Martin RW; Clark JI
    Ultrasound Med Biol; 2002 Jun; 28(6):823-9. PubMed ID: 12113795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit.
    Lee YH; Lee VH
    J Ocul Pharmacol; 1993; 9(1):47-58. PubMed ID: 8463732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.